Eric Nadler

5.1k citations
43 papers · 3.9k · 1 hit paper · h-index 18

Impact in

Papers in

    • Lung Cancer Treatments and Mutations 13
    • Sarcoma Diagnosis and Treatment 4
    • Lung Cancer Diagnosis and Treatment 3
    • Prostate Cancer Treatment and Research 2
    • Economic and Financial Impacts of Cancer 7
    • Health Systems, Economic Evaluations, Quality of Life 5

Eric Nadler

43 papers receiving 3.8k citations

Eric Nadler's Hit Papers

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study 2019 · 2.5k citations
2.5k0+2+4Years since publication5001k1.5k2k

Peers

Eric Nadler
Comparison fields: 5 of 114
  • Otorhinolaryngology 1.3k
  • Oncology 1.4k
  • Pulmonary and Respiratory Medicine 534
  • Economics and Econometrics 368
  • General Health Professions 261
Replace Elizabeth A. Handorf with:
Elizabeth A. Handorf United States
Shripad Dinanath Banavali India
Bruce Brockstein United States
Marcy A. List United States
Richard William Gregg Canada
María José Bento Portugal
Simron Singh Canada
Laura Botta Italy
Andrea Tavilla Italy
June F. Corry Australia
Eric Nadler relative to Elizabeth A. Handorf United States Elizabeth A. Handorf's profile →
Citations per field
00.5×2×3.2×
Elizabeth A. Handorf · 1×
Citations per year

Countries citing papers authored by Eric Nadler

Since Specialization
Citations

This map shows the geographic impact of Eric Nadler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Nadler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Nadler more than expected).

Fields of papers citing papers by Eric Nadler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Nadler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Nadler. The network helps show where Eric Nadler may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Nadler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Nadler Line = papers co-authored together Eric Nadler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Hit paper breakdown →
20192497
2 2011293
3 1997254
4 2006162
5 2010124
6 201068
7 200960
8 201838
9 202035
10 200034
11 201125
12 201223
13 201022
14 202221
15 200520
16 201320
17 201419
18 202019
19 201718
20 199916

About Eric Nadler

Eric Nadler is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics, Otorhinolaryngology, Oncology and General Health Professions, having authored 43 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Economic and Financial Impacts of Cancer (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Head and Neck Cancer Studies (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Otorhinolaryngology (1.3k citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (534 citations), Economics and Econometrics (368 citations) and General Health Professions (261 citations). Eric Nadler has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Peter J. Neumann, Peter Anthony Ubel, Douglas J. Rupert, Neeraj K. Arora, Lauren McCormack, Richard Lewis Street, Pamela A. Williams-Piehota, Katherine Treiman, William Lawrence and Murray F. Brennan. Their work appears in journals such as Future Oncology, Clinical Colorectal Cancer, Health Affairs, Advances in Therapy and Sarcoma.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact